Literature DB >> 35112910

Identification of the First SARS-CoV-2 Lineage B.1.1.529 Virus Detected in Europe.

Bert Vanmechelen1, Anne-Sophie Logist1, Tony Wawina-Bokalanga1, Jens Verlinden1, Joan Martí-Carreras1, Caspar Geenen2, Bram Slechten2, Lize Cuypers2,3, Emmanuel André2,3, Guy Baele1, Piet Maes1.   

Abstract

We report the complete genome sequence of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (lineage B.1.1.529) from a Belgian patient with a history of recent travel to Egypt. At the time of writing, this genome constituted the first confirmed case of an infection with the Omicron variant in Europe.

Entities:  

Year:  2022        PMID: 35112910      PMCID: PMC8812313          DOI: 10.1128/mra.01161-21

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

In December 2019, a novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (genus Betacoronavirus, subfamily Orthocoronavirinae, family Coronaviridae), was identified in Wuhan, China (1, 2). Following its spread to the rest of the world, many unique mutations in the virus genome have been reported. The biological advantages conferred by some of these mutations have resulted in the establishment of specific genetic lineages that have largely outcompeted the original strain (3). Lineages that are characterized by increased transmissibility or virulence or that decrease the effectiveness of available countermeasures are classified by the WHO as variants of concern (VOCs) (4). On 26 November 2021, 2 days after it was reported for the first time in South Africa, a new lineage (B.1.1.529) was classified as variant Omicron, the fifth recognized VOC (5). Here, we report the genome sequence of the first reported Omicron variant in Europe. The sample was collected as part of routine COVID-19 diagnostics and selected for whole-genome sequencing following an S gene dropout in quantitative PCR (qPCR) testing (TaqPath COVID-19 CE-IVD reverse transcription [RT]-PCR kit; Thermo Fisher Scientific). This work was reviewed and approved by the KU/UZ Leuven Clinical Trial and Ethical review board (approval number S66037), which allows us to use patient samples for research and lookup and use specific metadata from the patient. The patient returned from Egypt to Belgium on 11 November 2021 and tested negative 3 days before travelling, as well as repeatedly testing negative during quarantine after arrival in Belgium. The patient developed mild symptoms 10 days after arrival and tested positive for SARS-CoV-2 on 24 November 2021. RNA was extracted from a nasopharyngeal swab sample using the QIAamp viral RNA minikit (Qiagen, Hilden, Germany), after which a barcoded Nanopore sequencing library was prepared using the COVID Midnight midikit (C19MIDI; Oxford Nanopore Technologies), which uses a tiled amplicon approach (∼1,200-bp amplicons) to amplify the SARS-CoV-2 genome. The library was sequenced for 72 h on an R9.4.1 flow cell. Base calling and demultiplexing were done using the GridION built-in MinKNOW software (v21.05.25), and the resulting reads were processed using the ARTIC bioinformatics pipeline v1.1.3 (6). The genome sequence obtained has a total length of 29,684 nucleotides and a GC content of 38%, with an average coverage depth of 1,501×. Because the genome termini are not covered by the amplicons used, the 54 first (5′) and 151 last (3′) nucleotides, compared to the SARS-CoV-2 reference genome (GenBank accession number NC_045512.2), are not present in this sequence. Nextclade v1.10.0 was used for comparison with the RefSeq sequence (7). This genome contains 54 mutations and 39 indels (Table 1), compared to the RefSeq sequence, highlighting the strong divergence of this novel variant.
TABLE 1

Mutations of SARS-CoV-2 strain hCoV-19/Belgium/rega-20174/2021 in comparison with the reference strain (GenBank accession number NC_045512.2)

Gene or regionaNucleotide position(s)Amino acid changebCoding sequence codon position(s)bNucleotide changeb
ORF1a241C to T
2832K to R856A to G
3037C to T
5386T to G
6513–6515S deletion2083
8393A to T2710G to A
10029T to I3255C to T
10449P to H3395C to A
11285–11293LSG deletion3674–3676
11537I to V3758A to G
13195T to C
ORF1b14408P to L314C to T
15240C to T
18163I to V1566A to G
S21762C to T
21765–21770HV deletion69–70
21846T to I95C to T
21987–21995GVY deletion142–144
22194–22196N deletion211
22578G to D339G to A
22673–22674S to L371TC to CT
22679S to P373T to C
22686S to F375C to T
22813K to N417G to T
22882N to K440T to G
22898G to S446G to A
22992S to N477G to A
22995T to K478C to A
23013E to A484A to C
23040Q to R493A to G
23048G to S496G to A
23055Q to R498A to G
23063N to Y501A to T
23075Y to H505T to C
23202T to K547C to A
23403D to G614A to G
23525H to Y655C to T
23599N to K679T to G
23604P to H681C to A
23854N to K764C to A
23948D to Y796G to T
24130N to K856C to A
24424Q to H954A to T
24469N to K969T to A
24503L to F981C to T
25000C to T
ORF3a25584C to T
E26270T to I9C to T
M26530D to G3A to G
26577Q to E19C to G
26709A to T63G to A
ORF627259A to C
ORF7b27807C to T
N28271A to T
28311P to L13C to T
28362–28370ERS deletion31–33
ORF9b28362–28370ENA deletion27–29
N28881–28883RG to KR203–204GGG to AAC

ORF, open reading frame.

—, no amino acid or codon change occurred, and no nucleotide change occurred when a deletion was detected.

Mutations of SARS-CoV-2 strain hCoV-19/Belgium/rega-20174/2021 in comparison with the reference strain (GenBank accession number NC_045512.2) ORF, open reading frame. —, no amino acid or codon change occurred, and no nucleotide change occurred when a deletion was detected. A phylogenetic analysis was performed using all available B.1.1.529 genomes in GISAID on 27 November 2021, along with a few representative genomes of the different VOCs (to root the phylogeny). MAFFT v7.475 was used to align the genome sequences, and the initial tree was generated using IQ-TREE v2.1.3 with automated model selection (8, 9). Following inspection of the resulting phylogeny using TempEst v1.5.3, nine outliers were removed to allow the subsequent estimation of a time-calibrated phylogeny using TreeTime v0.8.1 (10, 11). The resulting tree was visualized using FigTree v1.4.4 (Fig. 1). The phylogenetic analysis shows that the sequence reported here, hCoV-19/Belgium/rega-20174/2021, clusters as part of a larger clade with South African cases, the two previously confirmed cases from Hong Kong, and the one confirmed case from Israel.
FIG 1

Time-calibrated phylogenetic tree of strain hCoV-19/Belgium/rega-20174/2021 (highlighted in red) in a clade of the most closely related Omicron variant sequences (black). EPI_ISL_ numbers in the entries are GISAID accession numbers.

Time-calibrated phylogenetic tree of strain hCoV-19/Belgium/rega-20174/2021 (highlighted in red) in a clade of the most closely related Omicron variant sequences (black). EPI_ISL_ numbers in the entries are GISAID accession numbers.

Data availability.

This sequence has been deposited in GISAID (accession number EPI_ISL_6794907) and GenBank (accession number OL672836). The accession numbers for the raw sequencing reads in the NCBI Sequence Read Archive (SRA) are PRJNA784547 and SRR17066006.
  3 in total

1.  Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022.

Authors:  Nina Van Goethem; Pui Yan Jenny Chung; Marjan Meurisse; Mathil Vandromme; Laurane De Mot; Ruben Brondeel; Veerle Stouten; Sofieke Klamer; Lize Cuypers; Toon Braeye; Lucy Catteau; Louis Nevejan; Joris A F van Loenhout; Koen Blot
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

2.  Nationwide Harmonization Effort for Semi-Quantitative Reporting of SARS-CoV-2 PCR Test Results in Belgium.

Authors:  Lize Cuypers; Jannes Bode; Kurt Beuselinck; Lies Laenen; Klaas Dewaele; Reile Janssen; Arnaud Capron; Yves Lafort; Henry Paridaens; Bertrand Bearzatto; Mathieu Cauchie; Aline Huwart; Jonathan Degosserie; Olivier Fagnart; Yarah Overmeire; Arlette Rouffiange; Ilse Vandecandelaere; Marine Deffontaine; Thomas Pilate; Nicolas Yin; Isabel Micalessi; Sandrine Roisin; Veronique Moons; Marijke Reynders; Sophia Steyaert; Coralie Henin; Elena Lazarova; Dagmar Obbels; François E Dufrasne; Hendri Pirenne; Raf Schepers; Anaëlle Collin; Bruno Verhasselt; Laurent Gillet; Stijn Jonckheere; Philippe Van Lint; Bea Van den Poel; Yolien Van der Beken; Violeta Stojkovic; Maria-Grazia Garrino; Hannah Segers; Kevin Vos; Maaike Godefroid; Valerie Pede; Friedel Nollet; Vincent Claes; Inge Verschraegen; Pierre Bogaerts; Marjan Van Gysel; Judith Leurs; Veroniek Saegeman; Oriane Soetens; Merijn Vanhee; Gilberte Schiettekatte; Evelyne Huyghe; Steven Martens; Ann Lemmens; Heleen Nailis; Kim Laffineur; Deborah Steensels; Elke Vanlaere; Jérémie Gras; Gatien Roussel; Koenraad Gijbels; Michael Boudewijns; Catherine Sion; Wim Achtergael; Wim Maurissen; Luc Iliano; Marianne Chantrenne; Geert Vanheule; Reinoud Flies; Nicolas Hougardy; Mario Berth; Vanessa Verbeke; Robin Morent; Anne Vankeerberghen; Sébastien Bontems; Kaat Kehoe; Anneleen Schallier; Giang Ho; Kristof Bafort; Marijke Raymaekers; Yolande Pypen; Amelie Heinrichs; Wim Schuermans; Dominique Cuigniez; Salah Eddine Lali; Stefanie Drieghe; Dieter Ory; Marie Le Mercier; Kristel Van Laethem; Inge Thoelen; Sarah Vandamme; Iqbal Mansoor; Carl Vael; Maxime De Sloovere; Katrien Declerck; Elisabeth Dequeker; Stefanie Desmet; Piet Maes; Katrien Lagrou; Emmanuel André
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

3.  Borneol Ester Derivatives as Entry Inhibitors of a Wide Spectrum of SARS-CoV-2 Viruses.

Authors:  Olga I Yarovaya; Dmitriy N Shcherbakov; Sophia S Borisevich; Anastasiya S Sokolova; Maxim A Gureev; Edward M Khamitov; Nadezda B Rudometova; Anastasiya V Zybkina; Ekaterina D Mordvinova; Anna V Zaykovskaya; Artem D Rogachev; Oleg V Pyankov; Rinat A Maksyutov; Nariman F Salakhutdinov
Journal:  Viruses       Date:  2022-06-14       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.